Supernus Pharmaceuticals, Inc. (formerly Shire Laboratories) is a specialty pharmaceuticals company that has a broad portfolio of proven and patented drug delivery technologies. Among its key technologies are ProScreenŽ and OptiScreenŽ for lead selection and formulation optimization, MicrotrolŽ, SolutrolŽ and EnSoTrolŽ, its oral controlled release technologies, and AvertSM, its reduced abuse potential technology. Supernus is focused on developing differentiated products for targeted specialty therapeutic areas on its own and in partnership with other pharmaceutical companies.
